Αν και δεν καταλαβαίνω απόλυτα τι ακριβώς μας έχεις γράψει, αν μπορείς εξήγησε τι εννοείς, αλλά με μια απλή αναζήτηση βρήκα αυτό:
SMOFlipid is a multi-oil blend (soy, MCT, olive, fish) offering a balanced omega-3-to-omega-6 ratio and anti-inflammatory benefits, making it better for reducing liver issues (PNAC) in long-term parenteral nutrition, while traditional Intralipid is 100% soybean oil, high in omega-6 and phytosterols, potentially causing more inflammation but providing essential fatty acids. Think of SMOFlipid as a more sophisticated, balanced option for chronic use (especially in kids), reducing liver risk, whereas Intralipid is simpler but might trigger inflammation.
SMOFlipid (Mixed-Oil)
Composition: A blend of soybean oil (30%), MCT oil (30%), olive oil (25%), and fish oil (15%).
Benefits: Lower ω-6:ω-3 ratio, reduced inflammation, lower phytosterol content, and better prevention of Parenteral Nutrition-Associated Cholestasis (PNAC).
Best For: Patients needing long-term parenteral nutrition (PN), especially infants with intestinal failure (IF).
Intralipid (Soybean Oil)
Composition: 100% soybean oil.
Drawbacks: High ω-6 and phytosterol content, linked to increased inflammation and PNAC.
Best For: Older, stable patients, though SMOFlipid is often preferred for extended PN.
Key Differences
Oil Source: SMOFlipid = 4 oils; Intralipid = 1 oil (soy).
Inflammation: SMOFlipid is less inflammatory due to its ω-3 content from fish oil.
Liver Health: SMOFlipid significantly reduces liver disease risk (PNAC) compared to Intralipid.
In essence, SMOFlipid offers a more advanced, anti-inflammatory profile, making it a superior choice for complex, long-term nutritional support, particularly in pediatric cases prone to liver complications.
Εντάξει δεν το θέλουμε και για μακροχρόνια χρήση.. εγώ πάντως intralipid έκανα με σύσταση ανοσολογου/ρευματολογου με εξειδίκευση στην κύηση. Από εκεί και πέρα ότι σου λέει ο γιατρός σου!